Lawsuit Seeking Info on FDA’s Approval of RU 486 Abortion Drug Continues

National   |   Steven Ertelt   |   Apr 24, 2006   |   9:00AM   |   WASHINGTON, DC

Lawsuit Seeking Info on FDA’s Approval of RU 486 Abortion Drug Continues Email this article
Printer friendly page

by Steven Ertelt
LifeNews.com Editor
April 24, 2006

Washington, DC (LifeNews.com) — The dangerous RU 486 abortion drug has claimed the lives of at least nine women worldwide and six in the United States. A lawsuit getting a hearing Tuesday in a federal appeals court is seeking information about why the Clinton administration approved the drug in the first place.

During the waning days of the Clinton administration, the Food and Drug Administration hurriedly approved the mifepristone abortion drug under a special protocol normally reserved for crucial lifesaving medicines.

Judicial Watch, a governmental watchdog group, filed a lawsuit to obtain more than 4,000 documents pertaining to the RU 486 approval process the FDA continues to withhold.

"The FDA continues to abuse the open records process by withholding pertinent health information from the public," said Judicial Watch President Tom Fitton, in a statement provided to LifeNews.com.

"We’re tired of the FDA’s stonewalling the public’s right to know about the political motivations behind the RU-486 approval process, as well as the inherent dangers of this abortion drug."

Through the use of the Freedom of Information Act, and later through litigation, Judicial Watch discovered that the FDA approved RU 486 under the "Accelerated Approval of New Drugs for Serious or Life-threatening Illnesses," a measure adopted to encourage the manufacture and importation of drugs designed to treat illnesses such as cancer or heart disease.

Judicial Watch also discovered paperwork regarding the abortion drug trials that revealed serious health complications resulting from the use of the drug.

More than 840 women were listed in "Adverse Event Reports" that describe hospitalizations, severe infections, internal bleeding and other complications. The FDA has since admitted that figure is correct and that women suffered from incomplete abortions and other post-abortion problems that were, in many cases, life-threatening.

The FDA partially complied with a court order by releasing 9,300 documents to Judicial Watch. However, the organization reports that another 4,000 documents are still being withheld.

The U.S. Court of Appeals for the District of Columbia Circuit will hold the hearing on Tuesday in the case of Judicial Watch, Inc. v. Food and Drug Administration, et al.

Related web sites:
Judicial Watch – https://www.judicialwatch.org